Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

The Upper Austrian startup GENSPEED® Biotech develops a rapid test system for hospital bacteria and periodontal pathogens

GENSPEED®-Technology © GENSPEED® Biotech GmbH

Infections caused by antibiotic-resistant hospital bacteria that occur during hospital stays or infections with periodontal pathogens can result in serious consequences for affected patients. Both the detection of hospital bacteria in hospitals and the detection of periodontal pathogens in the dental field can take several days. The patient samples must either be examined through the use of lengthy in-house analyses or sent to external laboratories. With the rapid tests from GENSPEED® Biotech, hospital bacteria can be detected in the hospital laboratory in just 100 minutes, and periodontal pathogens can be detected in just 20 minutes directly at the dentist's practice. In both cases, rapid diagnosis allows for an immediate, targeted start of treatment. The GENSPEED immediate diagnosis system is a patented technology based on microfluid biochips, miniaturized optical detection and automation. In other words, the sample (e.g. from a nasal smear) is processed using standard methods and dripped into a so-called microfluid chip. No further intervention is required by the user, who can read the test result on the computer after a short time.

 

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 4. Mittelstandsforum Nordrhein-Westfalen

    18.06.2019, Dusseldorf, Germany

  • Expand to Austria

    26.06.2019, Brescia, Italy

Austria Map

Find the perfect location for your company

Reliability and expertise in the country and in the company are the convincing factors in selecting a business location. We can be justifiably proud but can still become even more attractive. This is something Austria should increasingly work on in the future!

Pfizer

Logo
More testimonials

news from the business location Austria

A.T. Kearney: Austria improves in the investment ranking

The inflows related to foreign direct investments in Europe in 2018 fell by 73 percent to USD 100 billion from the prior-year level of USD 372 billion.

Innovations from Austria for the Logistics Sector

At the present time there are many influencing factors which pose challenges to the supply chain and logistics management. Solutions in this area are frequently developed by startups, also from Austria. Several of them will present their innovations at the Austrian Logistics Day and Logistics Future Lab.

More news All blog posts